RecruitingPhase 4NCT07376148
Fractional CO2 Laser-assisted Delivery of Hyaluronic Acid, Ascorbic Acid and Sodium DNA For Enhancing Facial Skin Quality in Individuals Over the Age of 30
Sponsor
Instituto de Oftalmología Fundación Conde de Valenciana
Enrollment
30 participants
Start Date
Nov 7, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Evaluate the effectiveness of topical hyaluronic acid, ascorbic acid, and sodium DNA following ablative fractional laser treatment in objectively reversing facial skin alterations induced by photoaging.
Eligibility
Min Age: 30 Years
Inclusion Criteria1
- Male and female subjects, over 30 years of age, with moderate skin changes associated with elasticity, wrinkles, roughness, pigmentation, erythema, and pore size; with at least 12 points on the SASSQ scale. Fitzpatrick skin type I-III. Participants who agree to take part in the protocol
Exclusion Criteria1
- Fitzpatrick skin type IV-VI. Local infections or inflammatory disorders.. Neoplasms suspected of being malignant. Allergy to hyaluronic acid, ascorbic acid, and sodium DNA. Hypersensitivity to fractional CO2 laser. Pregnancy or breastfeeding. Local or systemic adverse reaction
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGtopical hyaluronic acid, ascorbic acid, and sodium DNA following ablative fractional laser treatment
The study involves the application of ascorbic acid, hyaluronic acid, and sodium DNA in preparation for their use following the administration of a fractional CO2 laser treatment
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07376148